Skip to content
10-Q

Quarterly Report

PHARMAGREEN BIOTECH INC. PHBI

0001477932-21-005724

← back to feed
Filed
Aug 18, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Aug 12, 2021 355.83M sh
Stockholders Equity Q3 2021 · Jun 30, 2021 −$1.84M
Stockholders Equity Q3 2021 · Mar 31, 2021 −$1.87M
Stockholders Equity Q3 2021 · Dec 31, 2020 −$1.75M
Stockholders Equity Q3 2021 · Sep 30, 2020 −$2.93M
Stockholders Equity restated Q3 2021 · Jun 30, 2020 −$2.24M
Stockholders Equity Q3 2021 · Mar 31, 2020 −$1M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$1.05M
Stockholders Equity restated Q3 2021 · Sep 30, 2019 −$834.5K
Current Liabilities Q3 2021 · Jun 30, 2021 $1.82M
Current Liabilities Q3 2021 · Sep 30, 2020 $3.17M
Total Liabilities Q3 2021 · Jun 30, 2021 $1.86M
Total Liabilities Q3 2021 · Sep 30, 2020 $3.2M
Total Assets Q3 2021 · Jun 30, 2021 $19.31K
Total Assets Q3 2021 · Sep 30, 2020 $266.25K
Operating Cash Flow Q3 2021 · Jun 30, 2020 −$546.55K
Sga Expense restated Q3 2021 · Jun 30, 2020 $28.7K
Sga Expense restated Q3 2021 · Jun 30, 2020 $91.69K
Net Income restated Q3 2021 · Jun 30, 2020 −$1.36M
Net Income restated Q3 2021 · Jun 30, 2020 −$1.57M
Net Income Q3 2021 · Mar 31, 2020 −$3.63K
Net Income Q3 2021 · Dec 31, 2019 −$206.06K
Operating Income Q3 2021 · Jun 30, 2020 −$86.91K
Operating Income Q3 2021 · Jun 30, 2020 −$354.63K